Boehringer Ingelheim Pharmaceuticals

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. We are committed to offering the highest quality products to treat diseases, and bringing more health to patients and their families. Leveraging our heritage with deep scientific and disease understanding, we are focusing on therapies to treat cardiometabolic and respiratory diseases, oncology, inflammatory diseases, diseases of the central nervous system and retinopathies. We create value through innovation with a clear goal: to transform the lives of patients in areas of significant unmet medical need. Inspired by patients, our passion comes from believing in the importance of our work toward reaching that goal.